Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-010962
Filing Date
2025-04-17
Accepted
2025-04-17 18:28:43
Documents
2
Period of Report
2025-04-15

Document Format Files

Seq Description Document Type Size
1 form3-04172025_100440.html 3  
1 form3-04172025_100440.xml 3 1676
2 ex24-04172025_100440.htm EX-24 6217
  Complete submission text file 0001415889-25-010962.txt   9550
Mailing Address RADIUS HEALTH, INC. 201 BROADWAY, 6TH FLOOR CAMBRIDGE MA 02139
Business Address
WYZGA MICHAEL S (Reporting) CIK: 0001201256 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36279 | Film No.: 25848764

Mailing Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478
Business Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 (713) 489-8654
Tvardi Therapeutics, Inc. (Issuer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)